Whooping Cough in Vaccinated Children
Treat all vaccinated children with confirmed or suspected pertussis with azithromycin for 5 days, using age-appropriate dosing, regardless of vaccination status—antibiotics eradicate bacterial carriage and reduce transmission even though they don't alter the clinical course once symptoms begin. 1
Treatment Approach
Primary Antibiotic Regimen
The vaccination status of the child does NOT change the treatment approach. Azithromycin is the first-line agent for all children >1 month of age with pertussis 1:
- Infants <6 months: 10 mg/kg per day for 5 days
- Children ≥6 months: 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg per day (max 250 mg) on days 2-5
Alternative Agents
If azithromycin is unavailable or contraindicated 1:
- Clarithromycin: 7-day course (equally effective, better tolerated than erythromycin)
- Erythromycin: 40-50 mg/kg/day (max 2 g/day) in 4 divided doses for 14 days
- Critical caveat: Avoid in infants <1 month due to infantile hypertrophic pyloric stenosis (IHPS) risk
- Trimethoprim-sulfamethoxazole: Alternative for children ≥2 months with macrolide allergy
Key Clinical Principles
Timing Matters for Symptom Relief
Antibiotics administered early in the catarrhal stage (first 1-2 weeks) can reduce symptom duration and severity 1. However, once the paroxysmal cough stage begins, antibiotics will NOT alter the clinical course—they only eradicate bacterial carriage and prevent transmission 2, 3. This is why treatment is still indicated: to reduce the infectious period from 3-4 weeks down to 5 days after starting antibiotics 1.
Why Vaccinated Children Still Get Pertussis
Immunity from pertussis vaccination wanes after 5-10 years 1. Vaccinated children can develop pertussis, though typically with milder, atypical presentations—often just persistent cough without the classic "whoop" 3, 4. Do not dismiss prolonged cough in vaccinated children; test and treat appropriately.
Postexposure Prophylaxis for Contacts
Identify and treat close contacts with the same antibiotic regimen as treatment 1:
Who Requires Prophylaxis:
- All household contacts
- Infants <12 months (highest priority—severe disease risk)
- Pregnant women in third trimester
- Healthcare workers exposed to the case
- Anyone with direct face-to-face exposure or shared confined space for ≥1 hour
Timing Window:
Prophylaxis must be given within 21 days of cough onset in the index case to prevent symptomatic infection 1
Special Consideration:
Symptomatic contacts should be treated as cases, not given prophylaxis 1
Critical Pitfalls to Avoid
Don't delay treatment waiting for laboratory confirmation in clinically suspected cases—start antibiotics empirically, especially in young infants where pertussis can be fatal 5, 6
Never use erythromycin in neonates <1 month without monitoring for IHPS; azithromycin is strongly preferred in this age group 1
Don't assume vaccination provides complete protection—breakthrough infections occur and require the same treatment approach 1, 3
Avoid aluminum/magnesium antacids with azithromycin—they reduce absorption 1
Monitor drug interactions with erythromycin and clarithromycin (CYP3A inhibitors) but not azithromycin 1
Isolation and Return to Activities
- Respiratory isolation for 5 days after starting effective antibiotic therapy 7
- Without antibiotics, patients remain contagious for 3-4 weeks from cough onset 1
- Exclude from school/daycare during the 5-day treatment period
Vaccination Status Update
After treating pertussis in a vaccinated child, ensure the child completes their age-appropriate vaccination schedule—natural infection does not provide lifelong immunity 1, 4. Update household contacts' vaccination status as well 7.